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Abstract
Backround: To determine the extent of visual field loss in patients who had required a pars plana
vitrectomy secondary to complications of proliferative diabetic retinopathy.
Methods: Patients that had undergone a vitrectomy on at least one eye for treatment of either
vitreous haemorrhage or tractional retinal detachment were selected for study. ETDRS acuity and
Humphrey binocular Esterman visual field testing were performed and compared to the minimum
standards for safe driving as defined by the Royal College of Ophthalmologists in 1999. In addition
to this Goldman kinetic visual fields using a III4e and V4e stimulus size and central 24-2 threshold
test with the SITA-fast strategy were performed on the vitrectomised eye.
Results: 20 patients (n = 20) were recruited. Mean visual acuity in the eye being tested was 0.20
(Snellen 6/9.5). Results from the Humphrey field analyzer showed a mean number of abnormal
stimulus locations of 71.2% (p < 0.005). 70% of patients had sufficient binocular acuity to drive and
of these 71.4% were shown not to have a minimum visual field for safe driving on binocular
Esterman field analysis.
Conclusion: Vitrectomy potentially allows retention/restoration of good visual acuity in patients
with complications of proliferative diabetic retinopathy. However patients may be suffering from
unrecognized visual impairment consequent upon extensive visual field loss which in over two
thirds of patients may be sufficiently severe to preclude safe driving.
Backround
The necessity for a patient with proliferative diabetic retin-
opathy(PDR) to undergo a pars plana vitrectomy(PPV)
either as a result of vitreous haemorrhage(VH)[1] or trac-
tional retinal detachment (TRD) can be seen as a clinical
end point of severe proliferative diabetic retinopathy. This
group of patients will have inevitably suffered retinal
damage due to a combination of retinal ischaemia[2,3]
and panretinal laser photocoagulation(PRP)[4-13]. When
these patients are assessed clinically, much emphasis is
placed on their Snellen visual acuity as the main index of
their visual function. This clearly ignores the functionally
important aspect of visual fields. There have been many
studies looking at the effect of PRP on reducing visual
fields[4-13], however patients that have suffered VH or
TRD are often excluded from such studies. It is thus possi-
ble that field loss is under appreciated in this group of
patients.
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Using three main perimetric testing techniques and stand-
ardized field analysis our study aimed firstly to increase
our understanding of visual function and in particular vis-
ual fields in patients who have undergone a PPV for com-
plications of PDR. Secondly, our study aimed to
appreciate the impact of this visual field loss in terms of
the ability of these patients to satisfy the UK minimal legal
driving standard. Our study did not aim to distinguish
between the various retinal insults that contribute to field
loss in this group of patients, namely; PDR, PRP and the
PPV itself [2-13].
Methods
Consecutive patients who had undergone a pars plana vit-
rectomy (PPV) for treatment of haemorrhagic or trac-
tional complications of proliferative diabetic retinopathy
(PDR) over a six month period were selected by case note
review. Any patient shown to have signs of suspicion for
other causes of visual field loss, in particular glaucoma
was excluded. Log minimal angle of resolution visual acu-
ity(logMAR VA) was measured using an ETDRS test chart.
The operated eye, or in the cases where both eyes had
undergone surgery, the eye with the better acuity was
selected for monocular visual field testing. Monocular
Goldman kinetic visual fields using a standard Goldman
bowl perimeter with stimulus sizes of III4e (10,000 Asb, 0
dB, 4 mm2) and V4e (10,000 Asb, <0 dB, 64 mm2) and
monocular central 24-2 threshold test using a Humphrey
visual field analyzer (HFA) with the SITA-fast strategy[14]
were performed as well as binocular Esterman fields[15].
In each case appropriate near correction was employed in
presbyopic patients. Fifteen age-gender matched healthy
individuals additionally underwent Goldman field analy-
sis for later quantitative comparison using the same test
protocol.
The Goldman visual fields were cut out and weighed on
electronic scales accurate to 0.0001 g in order to produce
a quantitative representation of the overall field area. This
was done for both III4e and V4e respectively.
Humphrey 24-2 monocular sensitivity loss was measured
in terms of the number of stimulus locations with statisti-
cal probability levels of p less than 0.005. The count of
abnormal stimulus locations (i.e. those with a SITA anal-
ysis statistical significance level of p < 0.005) was under-
taken for the complete HFA program 24-2 field. Only
clusters of three or more abnormal stimulus locations
were included in the count, that is, a conservative criterion
of abnormality was used thereby minimizing type 1 exper-
imental error[10]. Mean deviation was also calculated for
the Humphrey fields. Further visual field assessment was
conducted using the binocular Esterman program of the
Humphrey visual field analyzer. These Esterman fields
were examined using the 1999 Royal College of Ophthal-
mologists definition for the minimum field for safe driv-
ing for group 1 ordinary drivers which states that 'the
minimum visual field for safe driving is a field of vision of
at least 120° on the horizontal meridian. In addition
there should be no significant field defect in the binocular
field which encroaches within 20° of fixation either above
or below the horizontal meridian'[16]. Significant and
therefore unacceptable central defects were defined by the
current driver and vehicle licensing agency (DVLA) guide-
lines as 1) a cluster of four or more contiguous points that
lies either wholly or partly within the central 20° area and
2) loss consisting of both a single cluster of 3 contiguous
missed points and any additional missed points within
the central 20° area.
The binocular BCVA was assessed for safe driving using
the Royal College of Ophthalmologists' definition of
'approximately 6/10 on the Snellen chart'(logMAR equiv-
alent 0.22). Only patients satisfying this requirement pro-
ceeded to have Esterman analysis. Any field test
considered to be unreliable, for example due to a high
number of fixation losses or false positive or negative
errors, was repeated. This was only necessary for three
patients and all three provided reliable fields on retesting.
Results
20 patients were recruited (n = 20) with a mean age of
50.8 years (Range 29–73 years); 55% were male. In 55%
of patients the diabetes was type 1; in the remaining 45%
it was type 2. The mean duration of diabetes was 24.3
years (range 11–43). Indications for PPV were as follows;
30% for TRD, 55% for VH and the remaining 15% for
both TRD and VH combined. All patients had in the past
received at least one session of panretinal photocoagula-
tion (PRP) to both eyes. Mean VA in the eye being tested
was 0.20 logMAR (Snellen equivalent 6/9.5) with a range
of VA from -0.1 to 0.7 logMAR. Of the 20 patients, 13
(65%) had a PPV and endolaser during vitrectomy on the
eye being tested and these 13 patients underwent Gold-
man visual field and Humphrey field analysis.
The mean weight of the cut out III4e Goldman visual
fields of the study patients was 0.5 g (range 0.1–1.1 g).
The healthy individuals' cut out Goldman fields showed a
mean weight of 1.3 g (range 1.3–1.4 g) at the III4e isopter.
Thus our patients had a III4e isopter which was 38% that
of healthy individuals (range 8 – 85%). At the V4e isopter,
study patients had a mean cut out Goldman visual field
weight of 0.8 g (range 0.2–1.4 g). Healthy individuals at
the V4e isopter had a mean cut out visual field weight of
1.7 g (range 1.6–1.7 g). Thus our patients had a V4e isop-
ter which was 49% that of healthy individuals (range 12 –
82%).BMC Ophthalmology 2006, 6:5 http://www.biomedcentral.com/1471-2415/6/5
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Results from the Humphrey field analyzer showed a mean
number of abnormal stimulus locations of 37 out of a
total of 52, i.e. 71.2% (range 44% to 94%). The average
mean deviation of all field plots was -16.02 dB (p < 0.005)
; range -8.58 to -24.73 dB.
70% of patients had sufficient binocular acuity to drive
and of these 71.4% were shown not to have a minimum
visual field for safe driving on binocular Esterman field
analysis. Of this 70% the mean binocular BCVA was 0.08
LogMAR (Snellen 6/7.5+1) with a range of -0.1 to 0.22
LogMAR. The mean BCVA of the weaker eye was 0.48 Log-
MAR (snellen 6/19+1) with a range of -0.18 to 1.0 Log-
MAR.
Discussion
It is important for Ophthalmologists to recognize the
extent of visual impairment suffered by patients with
severe proliferative diabetic retinopathy. Our study shows
the global nature of visual field loss in such patients. The
study patients had on average lost 62% and 51% of their
Goldman III4e and V4e visual field areas respectively and
using our conservative definition of three missed points
71% of their central 24 degrees vision on HFA analysis.
Only 20% were deemed visually fit to drive using current
DVLA acuity and visual field guidelines. This is despite an
average log MAR visual acuity of 0.20 (Snellen equivalent
6/9.5).
Our method of quantifying Goldman visual fields by cut
out weight has not to our knowledge been reported in the
literature. We used uniform and identical paper on which
to plot the Goldman fields and thus the cut out weight of
the visual field gives an accurate representation of the
overall area of the visual field.
Our rate of failure of Esterman fields for safe driving is
similar to original reports showing that 80% of patients
who have had bilateral PRP with a 500 micron burn for
PDR will fail the current DVLA field test[17]. Subsequent
reports utilizing smaller burns showed that fewer patients
fail the test[18].
Vitrectomy potentially allows retention/restoration of
good acuity in patients with complications of PDR. How-
ever patients may be suffering from unrecognized visual
impairment consequent upon extensive visual field loss
which in 75% of patients is sufficiently severe to preclude
safe driving.
Limitations of our study include a small sample size as
well as a difficulty in determining accurately from the
notes the location and extent of PRP that these patients
had in the past. Our study group may also have been
biased towards those with a good acuity outcome. Static
perimetry was not performed as part of the monocular
Goldman fields and thus our weighting method may
overestimate field survival due to the probability of scoto-
mas within the peripheral isopters.
We recommend that diabetic patients who require vitrec-
tomy secondary to complications of proliferative retinop-
athy are advised that their peripheral vision is likely to
have been greatly reduced and that they are unlikely to be
able to fulfill current UK driving regulations.
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